3
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Corticosteroids for rheumatic disease

1. Physiology, pharmacology, and therapeutic strategies

Pages 239-244 | Published online: 16 May 2016

References

  • Polley HT, Slocumb CH. Behind the scenes with cortisone and ACTH. Mayo Clin Proc 1976: 51(8): 471–7
  • Axelrod L. Glucocorticoid therapy. Medicine (Baltimore) 1976: 55(1): 39–65
  • Fauci AS, Dale DC, Balow JE. Glucocortieosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med 1976: 84(3): 304–15
  • Garber EK, Fan PT, Bluestone R. Realistic guidelines of corticosteroid therapy in rheumatic disease. Semin Arthritis Rheum 1981: 11(2) 231–56
  • Gugler R, Azarnoff DL. Drug protein binding and the nephrotic syndnome. Clin Pharmacokinet 1976: 1(1): 25–35
  • Lewis GP, Jusko WJ, Graves L, et al. Prednisone side-effects and serum-pmtein levels. Lancet 1971: 2(728): 778–80
  • Kozower M, Veatch L, Kaplan MM. Decreased clearance of prednisolone, a factor in the development of corticosteroid side effects. J Clin Endocrinol Metab 1974: 38(3): 407–12
  • Klinenberg JR, Miller F. Effect of corticosteroids on blood salicylate concentration. JAMA 1965: 194(6): 601–4
  • Christy NP. The clinical significance of pituitaryadrenal suppression by exogenous corticosteroids. J Chronic Dis 1973: 26(5): 261–4
  • Livanou T, Ferriman D, James VH. Recovery of hypothalamo-pituitary-adrenal function after corticosteroid therapy. Lancet 1967: 2(Oct): 856–9
  • Gwinup G, Johnson B. Clinical testing of the hypothalamic-pituitary-adrenocortical system in states of hypo- and hypercortisolism. Metabolism 1975: 24(6): 777–91
  • Byyny RL. Withdrawal from glucocorticoid therapy. N Engl J Med 1976: 295: 30–2
  • Dixon RB, Christy NP. On the various forms of corticosteroid withdrawal syndrome. Am J Med 1980: 68(2): 224–30
  • Bond WS. Toxic reactions and side effects of glucocorticoids in man. Am J Hosp Pharm 1977: 34(5): 479–85
  • Greyson ND. Radionuclide bone and joint imaging in rheumatology. Bull Rheum Dis 1979–80: 30(7): 1034–8
  • Gray RG, Tenenbaum J, Gottlieb ML. Local corticosteroid injection treatment in rheumatic disorders. Semin Arthritis Rheum 1981: 10(4): 231–54
  • Stubbs SS, Morrell RM. Intravenous methylprednisolone sodium succinate: adverse reactions reported in association with immunosuppressive therapy. Transplant Proc 1973: 5(Jun): 1145–6
  • Levy AL, Waldmann TA. The effect of hydrocortisone on immunoglobulin metabolism. J Clin Invest 1970: 49(9): 1679–84
  • The Boston Collaborative Drug Surveillance Program. Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol Ther 1972: 13(5): 694–8
  • Dannenberg AM Jr. The antiinflammatory effects of glucocorticosteroids: a brief review of the literature. Inflammation 1979: 3(3): 329–43
  • Schatz M, Patterson R, Kloner R, et al. The prevalence of tuberculosis and positive tuberculin skin tests in a steroid-treated asthmatic population. Ann Intern Med 1976: 84(3): 261–5
  • Myles AB, Schiller LF, Glass D, et al. Single daily dose corticosteroid treatment. Ann Rheum Dis 1976: 35(1): 73–6
  • Gluck OS, Murphy WA, Hahn TJ, et al. Bone loss in adults receiving alternate day glucocorticoid therapy: a comparison with daily therapy. Arthritis Rheum 1981: 24(7): 892–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.